Shenzhen Kangzhe Biotechnology Co., Ltd.
Shenzhen Kangzhe Biotechnology Co., Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study on the Mass Balance of [14C] CMS-D002 in Healthy Adult Participants in China | Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-08-26 | NCT07788482 | |
| Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, overnutrition | Not yet recruiting | Phase 1 | 2026-04-08 | NCT07518589 | |
| A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome | Recruiting | Phase 1 | 2026-04-08 | NCT07462780 | |
| Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia | Uterine Fibroids With Menorrhagia | Recruiting | Phase 2 | 2026-03-11 | NCT07402369 |